adjuvant

(redirected from Adjuvant treatment)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Adjuvant treatment: palliative treatment

adjuvant

[′aj·ə·vənt]
(pharmacology)
A material that enhances the action of a drug or antigen.
References in periodicals archive ?
However, in Europe adjuvant chemotherapy currently remains the standard of care for adjuvant treatment in R0/R1 resected pancreatic cancer: recent trials could not establish any benefit from adding radiation to chemotherapy, and its value in this context still remains an open question.
Women with breast cancer do not consistently receive adjuvant treatments that have been shown to increase survival.
Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A; Multicenter International Study of Oxaliplatin/5-Fluorouracil/ Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.
Last month, Pfizer received approval for adjuvant treatment in the
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
In the cases where cancer has spread from the breast into the lymphatic system, more effective adjuvant treatment is now being used in clinical trials.
NeuVax targets the remaining 50% of HER2 positive patients (HER2 1+ and 2+) who achieve remission with current standard of care, but have no available HER2 targeted adjuvant treatment options to maintain their disease free status.
The Company's lead product candidate is an investigational drug known as PB272 ("neratinib"), which the Company had touted as an extended adjuvant treatment of human epidermal growth factor receptor 2 ("HER2")-positive metastatic breast cancer.
The randomized, double-blind, placebo-controlled Phase III trial is evaluating regorafenib as an adjuvant treatment of colorectal cancer following resection of liver metastases with curative intent.
5 percent of patients had one or more CTC in their blood before the start of adjuvant treatment.
Targeting insulin as a therapeutic modality in breast cancer could be an option in the adjuvant treatment of breast cancer.